| Symbol |
Name |
|
ABCC11
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 11
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADORA2A
|
adenosine A2a receptor
|
|
ADORA3
|
adenosine A3 receptor
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AHSG
|
alpha-2-HS-glycoprotein
|
|
AIP
|
aryl hydrocarbon receptor interacting protein
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALG8
|
ALG8, alpha-1,3-glucosyltransferase
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
AR
|
androgen receptor
|
|
ARPC2
|
actin related protein 2/3 complex, subunit 2, 34kDa
|
|
ATG16L1
|
autophagy related 16-like 1 (S. cerevisiae)
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATMIN
|
ATM interactor
|
|
AURKB
|
aurora kinase B
|
|
AVPR1A
|
arginine vasopressin receptor 1A
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAX
|
BCL2-associated X protein
|
|
BCR
|
breakpoint cluster region
|
|
BIRC7
|
baculoviral IAP repeat containing 7
|
|
BPIFA4P
|
BPI fold containing family A, member 4, pseudogene
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
CBX4
|
chromobox homolog 4
|
|
CBX8
|
chromobox homolog 8
|
|
CCAR2
|
cell cycle and apoptosis regulator 2
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCNA2
|
cyclin A2
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CD40
|
CD40 molecule, TNF receptor superfamily member 5
|
|
CD40LG
|
CD40 ligand
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CEACAM3
|
carcinoembryonic antigen-related cell adhesion molecule 3
|
|
CEBPD
|
CCAAT/enhancer binding protein (C/EBP), delta
|
|
CHD1
|
chromodomain helicase DNA binding protein 1
|
|
CHI3L1
|
chitinase 3-like 1 (cartilage glycoprotein-39)
|
|
CLDN4
|
claudin 4
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CTGF
|
connective tissue growth factor
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSB
|
cathepsin B
|
|
CTSG
|
cathepsin G
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR2
|
chemokine (C-X-C motif) receptor 2
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYP11A1
|
cytochrome P450, family 11, subfamily A, polypeptide 1
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DYNC1H1
|
dynein, cytoplasmic 1, heavy chain 1
|
|
EGFR
|
epidermal growth factor receptor
|
|
EIF2AK3
|
eukaryotic translation initiation factor 2-alpha kinase 3
|
|
EIF5A2
|
eukaryotic translation initiation factor 5A2
|
|
EPO
|
erythropoietin
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
FBXW7
|
F-box and WD repeat domain containing 7, E3 ubiquitin protein ligase
|
|
FMN1
|
formin 1
|
|
FMO3
|
flavin containing monooxygenase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FN1
|
fibronectin 1
|
|
FOXD1
|
forkhead box D1
|
|
FOXL2
|
forkhead box L2
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXP2
|
forkhead box P2
|
|
FOXP3
|
forkhead box P3
|
|
G6PC3
|
glucose 6 phosphatase, catalytic, 3
|
|
GATA6
|
GATA binding protein 6
|
|
GHRL
|
ghrelin/obestatin prepropeptide
|
|
GNA12
|
guanine nucleotide binding protein (G protein) alpha 12
|
|
GNA13
|
guanine nucleotide binding protein (G protein), alpha 13
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GPBAR1
|
G protein-coupled bile acid receptor 1
|
|
GRB14
|
growth factor receptor-bound protein 14
|
|
GRN
|
granulin
|
|
H2AFX
|
H2A histone family, member X
|
|
HCN4
|
hyperpolarization activated cyclic nucleotide gated potassium channel 4
|
|
HGS
|
hepatocyte growth factor-regulated tyrosine kinase substrate
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-DRB4
|
major histocompatibility complex, class II, DR beta 4
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HMOX1
|
heme oxygenase 1
|
|
HNRNPD
|
heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)
|
|
HRH1
|
histamine receptor H1
|
|
HRH2
|
histamine receptor H2
|
|
HRH3
|
histamine receptor H3
|
|
HRH4
|
histamine receptor H4
|
|
HSD11B1
|
hydroxysteroid (11-beta) dehydrogenase 1
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
IAPP
|
islet amyloid polypeptide
|
|
IGFBP6
|
insulin-like growth factor binding protein 6
|
|
IL17A
|
interleukin 17A
|
|
IL2RG
|
interleukin 2 receptor, gamma
|
|
IL33
|
interleukin 33
|
|
ILK
|
integrin-linked kinase
|
|
IPMK
|
inositol polyphosphate multikinase
|
|
ITGA2B
|
integrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
JAK2
|
Janus kinase 2
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
LEP
|
leptin
|
|
LTA
|
lymphotoxin alpha
|
|
MAPT
|
microtubule-associated protein tau
|
|
MDC1
|
mediator of DNA-damage checkpoint 1
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MECOM
|
MDS1 and EVI1 complex locus
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MIA
|
melanoma inhibitory activity
|
|
MIR206
|
microRNA 206
|
|
MKL1
|
megakaryoblastic leukemia (translocation) 1
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MSH6
|
mutS homolog 6
|
|
MSTN
|
myostatin
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MYB
|
v-myb avian myeloblastosis viral oncogene homolog
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
NAMPT
|
nicotinamide phosphoribosyltransferase
|
|
NBN
|
nibrin
|
|
NEUROD1
|
neuronal differentiation 1
|
|
NF1
|
neurofibromin 1
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NLRP12
|
NLR family, pyrin domain containing 12
|
|
NLRP6
|
NLR family, pyrin domain containing 6
|
|
NOS1
|
nitric oxide synthase 1 (neuronal)
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NPR2
|
natriuretic peptide receptor 2
|
|
NPY
|
neuropeptide Y
|
|
NR0B1
|
nuclear receptor subfamily 0, group B, member 1
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR5A1
|
nuclear receptor subfamily 5, group A, member 1
|
|
NRG1
|
neuregulin 1
|
|
P2RY12
|
purinergic receptor P2Y, G-protein coupled, 12
|
|
PECAM1
|
platelet/endothelial cell adhesion molecule 1
|
|
PIAS1
|
protein inhibitor of activated STAT, 1
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PRC1
|
protein regulator of cytokinesis 1
|
|
PRNP
|
prion protein
|
|
PRODH
|
proline dehydrogenase (oxidase) 1
|
|
PROS1
|
protein S (alpha)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTPN1
|
protein tyrosine phosphatase, non-receptor type 1
|
|
RAD51
|
RAD51 recombinase
|
|
RTN4R
|
reticulon 4 receptor
|
|
RUNX1
|
runt-related transcription factor 1
|
|
S100A1
|
S100 calcium binding protein A1
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
SCG5
|
secretogranin V
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SHH
|
sonic hedgehog
|
|
SLC15A1
|
solute carrier family 15 (oligopeptide transporter), member 1
|
|
SLC3A1
|
solute carrier family 3 (amino acid transporter heavy chain), member 1
|
|
SLC45A3
|
solute carrier family 45, member 3
|
|
SLC7A9
|
solute carrier family 7 (amino acid transporter light chain, bo,+ system), member 9
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOD3
|
superoxide dismutase 3, extracellular
|
|
TCF7
|
transcription factor 7 (T-cell specific, HMG-box)
|
|
TERC
|
telomerase RNA component
|
|
TERT
|
telomerase reverse transcriptase
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFBR3
|
transforming growth factor, beta receptor III
|
|
TLR4
|
toll-like receptor 4
|
|
TLR9
|
toll-like receptor 9
|
|
TMPRSS2
|
transmembrane protease, serine 2
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator
|
|
TNFRSF12A
|
tumor necrosis factor receptor superfamily, member 12A
|
|
TNFSF12
|
tumor necrosis factor (ligand) superfamily, member 12
|
|
TP53
|
tumor protein p53
|
|
TPP2
|
tripeptidyl peptidase II
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TSC2
|
tuberous sclerosis 2
|
|
TTR
|
transthyretin
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
WWOX
|
WW domain containing oxidoreductase
|
|
YWHAQ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta
|
